Tokyo, Japan

Shinji Oie

This inventor holds 3 USPTO granted patents. Top assignees: Synphar Laboratories, Inc., Taiho Pharmaceutical Company Limited. Active years: 1996-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Oie. Retrieved from https://idiyas.com/inventor/shinji-oie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.2

ph-index = 1


Location History:

  • Iokushima, JP (1996)
  • Tokyo, JP (1997 - 1999)

Company Filing History:


Years Active: 1996-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Shinji Oie

Introduction

Shinji Oie is a prominent inventor based in Tokyo, Japan, known for his contributions to the field of medicinal chemistry. With a total of three patents to his name, he has made a significant impact on the development of novel compounds.

Latest Patents

Among his latest patents are the innovative compounds 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives and 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative. These inventions showcase his expertise in creating compounds that could have important implications in therapeutic applications.

Career Highlights

Throughout his career, Shinji Oie has worked with notable organizations such as Taiho Pharmaceutical Company Limited and Synphar Laboratories, Inc. His experience in these leading pharmaceutical companies has equipped him with the skills necessary to advance his innovative ideas.

Collaborations

Shinji has had the opportunity to collaborate with esteemed colleagues, including Toshio Otani and Hiroshi Matsumoto. These partnerships not only highlight his collaborative spirit but also reflect the dynamic environment in which he has operated, contributing to greater innovations.

Conclusion

In summary, Shinji Oie stands as a testament to the ingenuity found in Japan's bustling pharmaceutical sector. His patents not only advance scientific understanding but also serve as a foundation for future advancements in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…